Skip to content

Fatigue and Cancer Treatment(FACT)- an Exercise Intervention

Mitigating Cancer Treatment-Related Fatigue by Exercise

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00181129
Enrollment
140
Registered
2005-09-16
Start date
2002-09-30
Completion date
2008-05-31
Last updated
2018-12-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Fatigue

Keywords

Fatigue, Cancer treatment

Brief summary

The purpose of this randomized controlled trial is to determine the effects of a nurse-directed, home-based walking exercise program to mitigate fatigue and maintain physical functioning during adjuvant therapy for cancer. The sample will be randomized into exercise (EX) or usual care (UC) groups. The independent study variable is participation in a walking exercise program. Outcomes include: fatigue, sleep disturbance, emotional distress, physical functioning and quality of life. The effects of the walking exercise program will be evaluated using self-report questionnaires administered pre- and post-treatment, patient diaries, and symptoms assessments at defined intervals during adjuvant therapy

Interventions

BEHAVIORALhome based self paced walking program

Sponsors

Johns Hopkins University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Confirmed diagnosis of cancer (Stage 1,2,or 3), 21 years of age or older, Free of cognitive or physical deficits that would preclude entry into study, not currently exercising 120 min/wk or more

Exclusion criteria

Concurrent major health problems or disabilities that would limit participation in an exercise program. Stage 4 cancer (metastisis)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026